(Q34515426)

2 August 2017

title

Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol (English)

1 reference

beclomethasone dipropionate

2 August 2017

main subject

1 reference

P Fireman

1

1 reference

2 August 2017

B M Prenner

2

1 reference

2 August 2017

W Vincken

3

1 reference

2 August 2017

M Demedts

4

1 reference

2 August 2017

S J Mol

5

1 reference

2 August 2017

R M Cohen

6

1 reference

2 August 2017

publication date

1 May 2001

1 reference

Annals of Allergy, Asthma & Immunology

2 August 2017

published in

1 reference

2 August 2017

volume

86

1 reference

2 August 2017

issue

5

1 reference

2 August 2017

page(s)

557-565

1 reference

Chlorofluorocarbon-free inhalers: are we ready for the change?

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

New delivery systems and propellants

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Improved delivery of inhaled steroids to the large and small airways

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Standardization of spirometry--1987 update. Statement of the American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

The effects of inhaled glucocorticoids on bone mass and biochemical markers of bone homeostasis: a 1-year study of beclomethasone versus budesonide

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962905-5

7 January 2021

10.1016/S1081-1206(10)62905-5

Identifiers

DOI

1 reference

2 August 2017

1 reference